Cargando…
Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis
Systemic ATTR amyloidosis is an increasingly important protein misfolding disease that is provoked by the formation of amyloid fibrils from transthyretin protein. The pathological and clinical disease manifestations and the number of pathogenic mutational changes in transthyretin are highly diverse,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665346/ https://www.ncbi.nlm.nih.gov/pubmed/37993462 http://dx.doi.org/10.1038/s41467-023-43301-3 |
_version_ | 1785148849635983360 |
---|---|
author | Steinebrei, Maximilian Baur, Julian Pradhan, Anaviggha Kupfer, Niklas Wiese, Sebastian Hegenbart, Ute Schönland, Stefan O. Schmidt, Matthias Fändrich, Marcus |
author_facet | Steinebrei, Maximilian Baur, Julian Pradhan, Anaviggha Kupfer, Niklas Wiese, Sebastian Hegenbart, Ute Schönland, Stefan O. Schmidt, Matthias Fändrich, Marcus |
author_sort | Steinebrei, Maximilian |
collection | PubMed |
description | Systemic ATTR amyloidosis is an increasingly important protein misfolding disease that is provoked by the formation of amyloid fibrils from transthyretin protein. The pathological and clinical disease manifestations and the number of pathogenic mutational changes in transthyretin are highly diverse, raising the question whether the different mutations may lead to different fibril morphologies. Using cryo-electron microscopy, however, we show here that the fibril structure is remarkably similar in patients that are affected by different mutations. Our data suggest that the circumstances under which these fibrils are formed and deposited inside the body - and not only the fibril morphology - are crucial for defining the phenotypic variability in many patients. |
format | Online Article Text |
id | pubmed-10665346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106653462023-11-22 Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis Steinebrei, Maximilian Baur, Julian Pradhan, Anaviggha Kupfer, Niklas Wiese, Sebastian Hegenbart, Ute Schönland, Stefan O. Schmidt, Matthias Fändrich, Marcus Nat Commun Article Systemic ATTR amyloidosis is an increasingly important protein misfolding disease that is provoked by the formation of amyloid fibrils from transthyretin protein. The pathological and clinical disease manifestations and the number of pathogenic mutational changes in transthyretin are highly diverse, raising the question whether the different mutations may lead to different fibril morphologies. Using cryo-electron microscopy, however, we show here that the fibril structure is remarkably similar in patients that are affected by different mutations. Our data suggest that the circumstances under which these fibrils are formed and deposited inside the body - and not only the fibril morphology - are crucial for defining the phenotypic variability in many patients. Nature Publishing Group UK 2023-11-22 /pmc/articles/PMC10665346/ /pubmed/37993462 http://dx.doi.org/10.1038/s41467-023-43301-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Steinebrei, Maximilian Baur, Julian Pradhan, Anaviggha Kupfer, Niklas Wiese, Sebastian Hegenbart, Ute Schönland, Stefan O. Schmidt, Matthias Fändrich, Marcus Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis |
title | Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis |
title_full | Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis |
title_fullStr | Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis |
title_full_unstemmed | Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis |
title_short | Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis |
title_sort | common transthyretin-derived amyloid fibril structures in patients with hereditary attr amyloidosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665346/ https://www.ncbi.nlm.nih.gov/pubmed/37993462 http://dx.doi.org/10.1038/s41467-023-43301-3 |
work_keys_str_mv | AT steinebreimaximilian commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis AT baurjulian commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis AT pradhananaviggha commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis AT kupferniklas commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis AT wiesesebastian commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis AT hegenbartute commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis AT schonlandstefano commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis AT schmidtmatthias commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis AT fandrichmarcus commontransthyretinderivedamyloidfibrilstructuresinpatientswithhereditaryattramyloidosis |